c‐Myc deregulation is a common feature of most human cancers.[24, 25] Western blotting results showed that RTN4IP1 expression was consistent with that of c‐Myc in cells treated with BRD4 inhibitors (Figure S1H, Supporting Information). This evidence concerns the gene BRD4 and cancer.